|
|
| Line 3: |
Line 3: |
| Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} |
| {{#tree:id=OrganizedByTopic|openlevels=0| | | {{#tree:id=OrganizedByTopic|openlevels=0| |
| | |
| | *α-1B adrenergic receptor |
| | |
| | **[[7b6w]] – hA1AR + agonist<br /> |
| | |
| | *α-2 adrenergic receptor |
| | |
| | **[[6kuy]] – hA2AAR + partial agonist<br /> |
| | **[[1ho9]], [[1hod]] – hA2AR peptide (mutant) – NMR |
| | **[[1hof]], [[1hll]] - hA2AR peptide – NMR |
| | **[[6kuw]] – hA2ACR + cholesterol + quinolone derivative<br /> |
| | **[[6k41]], [[6k42]] – hA2AAR/A2BAR + Gunine nucleotide binding protein + scFv – Cryo EM<br /> |
| | **[[7ej0]], [[7ej8]], [[7eja]], [[7ejk]] – hA2AR + Guanine nucleotide binding protein + scFv + drug – Cryo EM<br /> |
| | **[[6kux]] – A2AR + antagonist – ''Spodoptera frugiperda''<br /> |
|
| |
|
| *α-2 adrenergic receptor | | *α-2 adrenergic receptor |
| Line 12: |
Line 26: |
|
| |
|
| **[[7bts]] – hB1AR/T4 lysozyme (mutant) + nanobody + epinephrine - human<br /> | | **[[7bts]] – hB1AR/T4 lysozyme (mutant) + nanobody + epinephrine - human<br /> |
| | **[[7bu6]], [[7bu7]] – hB1AR/endolysin + nanobody + epinephrine derivative<br /> |
| | **[[7bvq]] – hB1AR/endolysin + carazolol<br /> |
| **[[2y01]], [[4gpo]], [[5f8u]] – tB1AR fragment (mutant) – turkey<br /> | | **[[2y01]], [[4gpo]], [[5f8u]] – tB1AR fragment (mutant) – turkey<br /> |
| **[[1dep]] – tB1AR peptide - NMR<br /> | | **[[1dep]] – tB1AR peptide - NMR<br /> |
| Line 19: |
Line 35: |
| **[[4bvn]] - tB1AR + cyanopindolol<br /> | | **[[4bvn]] - tB1AR + cyanopindolol<br /> |
| **[[6h7j]], [[6h7l]], [[6h7m]], [[6h7n]], [[6h7o]], [[6ibl]] – tB1AR (mutant) + nanobody + thioredoxin + agonist<br /> | | **[[6h7j]], [[6h7l]], [[6h7m]], [[6h7n]], [[6h7o]], [[6ibl]] – tB1AR (mutant) + nanobody + thioredoxin + agonist<br /> |
| **[[7jjo]] - tB1AR + guanine nucleotide-binding protein + nanobody – Cryo EM<br /> | | **[[7s0f]], [[7s0g]] - tB1AR + guanine nucleotide-binding protein + drug – Cryo EM<br /> |
| | **[[7jjo]] - tB1AR + guanine nucleotide-binding protein + nanobody + drug – Cryo EM<br /> |
| **[[6tko]] - tB1AR + arrestin + antibody + modulator – Cryo EM<br /> | | **[[6tko]] - tB1AR + arrestin + antibody + modulator – Cryo EM<br /> |
|
| |
|
| Line 46: |
Line 63: |
| **[[4qkx]] – B2AR + R9 protein - llama<br /> | | **[[4qkx]] – B2AR + R9 protein - llama<br /> |
|
| |
|
| *Alpha-2 adrenergic receptor | | *β-3 adrenergic receptor |
| | |
| | **[[7dh5]], [[7xjh]], a[[7xji]] – B3AR + guanine nucleotide-binding protein + nanobody + drug – dog - Cryo EM<br /> |
|
| |
|
| **[[6kuy]] – hA2AAR + partial agonist<br />
| |
| **[[1ho9]], [[1hod]] – hA2AR peptide (mutant) – NMR
| |
| **[[1hof]], [[1hll]] - hA2AR peptide – NMR
| |
| **[[6kuw]] – hA2ACR + cholesterol + quinolone derivative<br />
| |
| **[[6k41]], [[6k42]] – hA2AAR/A2BAR + Gunine nucleotide binding protein + scFv – Cryo EM<br />
| |
| **[[6kux]] – A2AR + antagonist – ''Spodoptera frugiperda''<br />
| |
| }} | | }} |
| [[Category: Topic Page]] | | [[Category: Topic Page]] |
Updated on 28-August-2022
{"openlevels":0}
- α-1B adrenergic receptor
- α-2 adrenergic receptor
- 6kuy – hA2AAR + partial agonist
- 1ho9, 1hod – hA2AR peptide (mutant) – NMR
- 1hof, 1hll - hA2AR peptide – NMR
- 6kuw – hA2ACR + cholesterol + quinolone derivative
- 6k41, 6k42 – hA2AAR/A2BAR + Gunine nucleotide binding protein + scFv – Cryo EM
- 7ej0, 7ej8, 7eja, 7ejk – hA2AR + Guanine nucleotide binding protein + scFv + drug – Cryo EM
- 6kux – A2AR + antagonist – Spodoptera frugiperda
- α-2 adrenergic receptor
- 1ho9, 1hod – hA2AR peptide (mutant) – human - NMR
- 1hof, 1hll - hA2AR peptide – NMR
- β-1 adrenergic receptor
- 7bts – hB1AR/T4 lysozyme (mutant) + nanobody + epinephrine - human
- 7bu6, 7bu7 – hB1AR/endolysin + nanobody + epinephrine derivative
- 7bvq – hB1AR/endolysin + carazolol
- 2y01, 4gpo, 5f8u – tB1AR fragment (mutant) – turkey
- 1dep – tB1AR peptide - NMR
- 2y00, 2y02, 2y03, 2y04, 2vt4, 4ami, 4amj, 5a8e - tB1AR fragment (mutant) + agonist
- 2ycw, 2ycx, 2ycz, 2ycy - tB1AR fragment (mutant) + antagonist
- 3zpq, 3zpr - tB1AR fragment (mutant) + aryl piperazine inhibitor
- 4bvn - tB1AR + cyanopindolol
- 6h7j, 6h7l, 6h7m, 6h7n, 6h7o, 6ibl – tB1AR (mutant) + nanobody + thioredoxin + agonist
- 7s0f, 7s0g - tB1AR + guanine nucleotide-binding protein + drug – Cryo EM
- 7jjo - tB1AR + guanine nucleotide-binding protein + nanobody + drug – Cryo EM
- 6tko - tB1AR + arrestin + antibody + modulator – Cryo EM
- β-2 adrenergic receptor
- 6kr8 - hB2AR
- 3pds - hB2AR/T4 lysozyme
- 3p0g – hB2AR/T4 lysozyme + nanobody
- 4lde, 4ldl, 4ldo - hB2AR/T4 lysozyme (mutant) + nanobody
- 2r4s,2r4r - hB2AR + Fab5 complex
- 2rh1 - hB2AR/T4 lysozyme (mutant)
- 3d4s, 5d6l - hB2AR/T4 lysozyme (mutant) + cholesterol
- 4gbr - hB2AR/T4 lysozyme (mutant) + carazolol
- 6mxt - hB2AR/T4 lysozyme (mutant) + antibody + salmeterol
- 5x7d - hB2AR/T4 lysozyme (mutant) + carazolol + inhibitor
- 6oba - hB2AR/T4 lysozyme (mutant) + modulator
- 6ps0, 6prz, 6ps2, 6ps3, 6ps4, 6ps5, 6ps6 - hB2AR + cholesterol + carazolol derivative
- 6ps1 - hB2AR + cholesterol + timolol
- 5d5a, 5d5b - hB2AR (mutant) + cholesterol + carazolol
- 5jqh - hB2AR/T4 lysozyme (mutant) + carazolol + nanobody
- 3ny8, 3ny9, 3nya – hB2AR/T4 lysozyme + agonist
- 6n48 - hB2AR/endolysin + nanobody + modulator
- 3sn6 - human β-2 adrenergic receptor + nano body bound by guanine nucleotide-binding protein G
- 7bz2, 7dhi, 7dhr – hB2AR + guanine nucleotide-binding protein + nanobody + modulator – Cryo EM
- 3kj6, 2r4r, 2r4s – hB2AR + FAB heavy+light chains
- 4qkx – B2AR + R9 protein - llama
- β-3 adrenergic receptor
- 7dh5, 7xjh, a7xji – B3AR + guanine nucleotide-binding protein + nanobody + drug – dog - Cryo EM
